In total, 53.7% of participants with acromegaly and 74.6% of participants with Cushing’s disease received antihyperglycemic medication during the pre-randomization phase, mostly metformin, either alone or in addition to insulin received from baseline. The gene discussed is INS; the disease is acromegaly.